Side-by-side comparison of AI visibility scores, market position, and capabilities
Bengaluru micro-investing round-up app for Indian UPI payments acquired by CRED for $1.26M YC W20 company; 500,000 users validating behavioral savings automation that influenced Jar App and Groww round-up investing.
Spenny was a Bengaluru-based micro-investing fintech platform that automatically rounded up users' UPI digital payments to the nearest ₹10 and invested the difference into diversified mutual fund portfolios — the Indian equivalent of Acorns (US) — enabling passive wealth accumulation through behavioral savings automation without requiring active investment decisions. Founded in 2019 by Gaurav Arora and Rathin Shah and backed by Y Combinator (W20) with $1.26 million raised, Spenny scaled to 500,000 users before being acquired by CRED (Kunal Shah's fintech unicorn, $4.7 billion valuation) on June 23, 2023 — becoming part of CRED's financial services expansion strategy for India's credit card and premium consumer base.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.